Survey reveals skyrocketing interest in marijuana and cannabinoids
for pain.
These Companies are
aggressively building for this consumer confidence:
August 27, 2019 -- InvestorsHub
NewsWire -- via Corporate Ads --
The Target Group
(OTCQB: CBDY)
Positioned
to Serve the New Legal Cannabis Marketplace with High Quality
Supply Sources, an
innovative herbal vaporizer system and its
Own Established Growth Facility.
Based in Ontario, Canada is a
progressive, diversified, and vertically integrated cannabis investment
company. CBDY
has completed an
impressive growth facility and is expanding operations to build an
international network of manufacturing, distribution, production,
and sales operations. This company is creating an iconic brand
portfolio, leveraging product diversification, innovation, and
operational expertise to solidify long-term growth and
stability.
Target Group,
with the very appropriate trading symbol of CBDY, is positioned with the
assets, professional management experience and specific industry
expertise to address the needs of the new cannabis related
businesses emerging today.
In May of 2019
CBDY's wholly owned subsidiary, Canary Rx Inc. completed the
build-out of a new 44,000 sq. ft. cannabis production facility in
Norfolk County, Ontario. The production area is equipped with
sophisticated environmental control technology, custom-built to
regulate eight 2,200 sq. ft. flower rooms as well as vegetative,
breeding, testing, and curing spaces. Once fully operational,
this facility expected to produce 3,600kg of premium, organic
cannabis per year.
Also in Target
Group's Portfolio[KM1] is CannaKorp, Inc., which has developed the world's
first single-use pod, herbal vaporizer system, delivering
unprecedented quality, convenience and consistency. The complete
system includes the ground breaking vaporizer
device, WISP™, single-use,
precisely measured pods containing pre-ground, lab-tested botanical
herbs called WISP Pods™; and a proprietary pod-filling
process. CannaKorp, Inc. was founded on care
and commitment to patients and consumers, and is guided by a
philosophy of social and environmental responsibility.
In summary,
Target Group (CBDY)
is at a pivotal moment where an entire industry is just coming into
play and this company is ready to participate in a very significant
role. Learn more via the company websites:
Target Group,
Inc.
www.targetgroupinc.ca
and
Canary Rx
Inc.
www.canaryrx.com
Canopy Growth Corp. (CGC)
The first Canadian marijuana company, Canopy Growth Corp. is the
world's largest publicly traded weed company.
The company
owns and operates many brands, producing and marketing both medical
and recreational strains. Tweed is one of the company's most
popular brands, thanks to an association with rapper Snoop
Dogg.
For its 2019 fiscal year, it reported revenue of CAD 77.9 million
or nearly $60 million.
https://www.canopygrowth.com/
Acacia Diversified Holdings (OTCQB: ACCA)
Positioned
for a Key Role as a Trusted Supplier of Optimized Medical Cannabis
Solutions
The
ACCA
growth
facilities, located in both Florida and Tennessee, are
situated
indoors which offer distinct advantages,
particularly a much more controlled environment. In February 2019 ACCA
announced that
its wholly-owned
subsidiary
Eufloria
Medical of
Tennessee, had entered into a Hemp
Research Partnership with Tennessee State University
(TSU). Eufloria Medical will produce the
cannabis material for this important study. In May, Eufloria also reported that it has
completed phase one of the construction work for 16,000
Sq./ft of the indoor space at its
Tennessee farm. Phase two is
underway
now with specialized equipment being
installed.
www.acaciadiversifiedholdings.com
Aurora Cannabis Inc. (ACB)
Another big Canadian pot company, Aurora Cannabis became even
bigger in March by acquiring rival
MedReleaf in
a $250 million all-stock deal that was touted as the world's
largest marijuana deal to date.
Consolidating
operations will help the new entity cut costs and gain efficiency.
According to a press
release, Aurora
and MedReleaf
together
expect to produce over 570,000 kilograms per year of cannabis
through nine facilities in Canada and two in
Denmark.
Aurora debuted
on the Canadian venture stock exchange (TSX) in October 2016 and
trades in the U.S. on the NYSE.
https://www.auroramj.com/
Cronos
Group Inc. (CRON)
Nasdaq's
first pot stock,
Cronos
Group is a Toronto-based cultivator of medical marijuana.
In
addition to Canada, Cronos
serves
international markets, shipping its products to Germany, building a
facility in Israel, and starting a joint venture in
Australia. Cronos
Group does not
have a presence in the U.S. due to the uncertainty in
regulations.
As
of its 2018 fiscal year, the company generated $7.3 million in
revenue.
https://thecronosgroup.com/
DISCLAIMER:
CorporateAds.com (CA) is a third-party publisher and news
dissemination service provider. CA is NOT affiliated in any manner
with any company mentioned herein. CA is news dissemination
solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. CA's market
updates, news alerts and corporate profiles are NOT a solicitation
or recommendation to buy, sell or hold securities. The material in
this release is intended to be strictly informational and is NEVER
to be construed or interpreted as research material. All readers
are strongly urged to perform research and due diligence on their
own and consult a licensed financial professional before
considering any level of investing in stocks. All material included
herein is republished content and details which were previously
disseminated by the companies mentioned in this release or opinion
of the writer. CA is not liable for any investment decisions by its
readers or subscribers. Investors are cautioned that they may lose
all or a portion of their investment when investing in stocks. CA
has been compensated $1,000.00 for this release and HOLDS NO SHARES
OF ANY COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur.